Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pato

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Neurologia (Barcelona, Spain)|February 21, 2015
Cultural adaptation and validation of a peninsular Spanish version of the MSTCQ<sup>©</sup> (Multiple Sclerosis Treatment Concerns Questionnaire)E Muntéis Olivas, G Navarro Mascarell, J Meca Lallana, et al.
Multiple Sclerosis and Related Disorders|May 25, 2023
Alemtuzumab treatment in real clinical practice: Experience in a multicenter cohortA M López-Real, I Gonzalez, D M Solar, et al.
Epilepsy Research|February 23, 2021
Perampanel effectiveness and safety as early add-on treatment for focal-onset seizures: PEREAGAL studyX Rodríguez-Osorio, T Lema-Facal, E Rubio-Nazábal, et al.
Neurologia|October 29, 2021
Progression of a series of patients with relapsing-remitting multiple sclerosis treated for 7 years with natalizumab using the "no evidence of disease activity" parameterA Pato Pato, E Costa Arpín, A Rodríguez Regal, et al.
Revista Espanola De Enfermedades Digestivas|November 1, 1995
[Comparative study of the efficacy and tolerance of 2 types of colon cleansing]J Fernández Seara, P Pascual Rubín, M A Pato Rodríguez, et al.
Plos One|October 13, 2021
Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registryJ E Meca-Lallana, C Oreja-Guevara, D Muñoz, et al.
Revista De Neurologia|September 24, 2016
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Galicia]A Pato-Pato, L Midaglia, E Costa-Arpin, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Neurologia (Barcelona, Spain)|February 21, 2015
Cultural adaptation and validation of a peninsular Spanish version of the MSTCQ<sup>©</sup> (Multiple Sclerosis Treatment Concerns Questionnaire)E Muntéis Olivas, G Navarro Mascarell, J Meca Lallana, et al.
Multiple Sclerosis and Related Disorders|May 25, 2023
Alemtuzumab treatment in real clinical practice: Experience in a multicenter cohortA M López-Real, I Gonzalez, D M Solar, et al.
Epilepsy Research|February 23, 2021
Perampanel effectiveness and safety as early add-on treatment for focal-onset seizures: PEREAGAL studyX Rodríguez-Osorio, T Lema-Facal, E Rubio-Nazábal, et al.
Neurologia|October 29, 2021
Progression of a series of patients with relapsing-remitting multiple sclerosis treated for 7 years with natalizumab using the "no evidence of disease activity" parameterA Pato Pato, E Costa Arpín, A Rodríguez Regal, et al.
Revista Espanola De Enfermedades Digestivas|November 1, 1995
[Comparative study of the efficacy and tolerance of 2 types of colon cleansing]J Fernández Seara, P Pascual Rubín, M A Pato Rodríguez, et al.
Plos One|October 13, 2021
Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registryJ E Meca-Lallana, C Oreja-Guevara, D Muñoz, et al.
Revista De Neurologia|September 24, 2016
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Galicia]A Pato-Pato, L Midaglia, E Costa-Arpin, et al.
Pageof 2